Rehovot

Maris-Tech Announces Collaboration with Global Semiconductor Powerhouse Renesas Electronics Corporation to Advance Edge Computing Solutions and Acceptance into its Preferred Partner Program

Retrieved on: 
Monday, March 25, 2024
Internet of things, Artificial intelligence, Renesas Electronics, AI, Edge, Rehovot

Rehovot, Israel, March 25, 2024 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a leading B2B provider of artificial intelligence (AI) accelerated video solutions for edge platforms, today announced a collaboration with Renesas Electronics Corporation (“Renesas”), one of the world’s largest semiconductor manufacturers, a global innovator in the field of microcontrollers, analog, and power devices, and acceptance into Renesas’ Preferred Partner Program.  In fiscal year 2023, Renesas had annual revenues in excess of US $9 billion and a market cap in excess of US $30 billion as of March 23, 2024.* This relationship has the potential to revolutionize commercial, security, and space markets through innovative edge-computing developments.

Key Points: 
  • * This relationship has the potential to revolutionize commercial, security, and space markets through innovative edge-computing developments.
  • Renesas combines its expertise in embedded processing, analog, power and connectivity to deliver complete semiconductor solutions.
  • Through this collaboration, Maris-Tech's AI and video analytics expertise will leverage Renesas's robust portfolio of microcontrollers to pioneer groundbreaking edge computing solutions.
  • "We are privileged to be selected as a Renesas Preferred Partner and a testament to Maris-Tech's ambition to redefine the Edge Computing landscape," said Israel Bar, Chief Executive Officer of Maris-Tech.

BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit

Retrieved on: 
Monday, February 26, 2024
Steps, Biotechnology, Food, Confidentiality, Plant, Biomass, NRE, Entrepreneurship, CDMO, Step, Safety, BHSC, Rehovot, Fine chemical

The new business unit allows pharmaceutical, cosmeceutical, nutraceutical and nutrition industry leaders the opportunity to partner with BioHarvest to utilize its Botanical Synthesis Process technology through a typical CDMO contracting model.

Key Points: 
  • The new business unit allows pharmaceutical, cosmeceutical, nutraceutical and nutrition industry leaders the opportunity to partner with BioHarvest to utilize its Botanical Synthesis Process technology through a typical CDMO contracting model.
  • This proprietary process technology enables the development and manufacturing of patentable plant based small molecules, complex molecules, and unique compositions which include both small and complex molecules.
  • As a result of these advantages, the Company has decided to call these unique plant-derived complex molecules BIOLOGICS+.
  • The CDMO business offers the Botanical Synthesis process technology in 3 major steps to its customers.

Maris-Tech Receives Repeat Order for Approximately $600,000 with an Option to Increase to Approximately $730,000 from a Company in the Defense Industry for its Unique Situational Awareness Solution

Retrieved on: 
Wednesday, February 21, 2024
Artificial intelligence, Rehovot

Rehovot, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of artificial intelligence (“AI”) accelerated video solutions for edge platforms, today announced that it has received a repeat order for approximately $600,000 from a leading company in the defense industry for a customized solution, that provides armored and autonomous vehicles with enhanced situational awareness. The customer also has an option to increase the order by $130,000 to approximately $730,000.

Key Points: 
  • The customer also has an option to increase the order by $130,000 to approximately $730,000.
  • The situational awareness system is based on Maris-Tech’s powerful Jupiter AI platform, incorporating advanced video streaming, recording, and AI-based capabilities that provide real-time intelligence to armored and autonomous vehicles.
  • The repeat order was received after the systems were installed and field-proven to the end customer’s complete satisfaction and approval.
  • The first order, as the Company announced on November 22, 2023, was for approximately $687,000, including exercising the customer’s option, reaching a total amount for the two orders of approximately $1,287,000 (or approximately $1,417,000 if the customer exercises the option in the current order).

BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Retrieved on: 
Thursday, February 15, 2024
Social media, Biotechnology, Innovation system, Health, Plant, City, BHSC, Synthesis, Alternative medicine, Rehovot, Wellness, Science, Fine chemical

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 15, 2024) - BioHarvest Sciences Inc. , (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology company pioneering botanical synthesis, has engaged investor relations specialists MZ Group (MZ) to lead a strategic investor relations and financial communications program across all key markets.

Key Points: 
  • Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 15, 2024) - BioHarvest Sciences Inc. , (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology company pioneering botanical synthesis, has engaged investor relations specialists MZ Group (MZ) to lead a strategic investor relations and financial communications program across all key markets.
  • MZ will work closely with BioHarvest management to develop and implement a comprehensive capital markets strategy designed to increase the Company's visibility throughout the investment community.
  • The company's first commercialized grape-derived product, VINIA®, is driving strong revenue growth as BioHarvest continues the launch of incremental product lines.
  • Individuals performing the services at MZ will be entitled to receive consultant options when granted by the board of BioHarvest.

VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences

Retrieved on: 
Wednesday, February 14, 2024
Research, Infectious Diseases, FDA, Clinical Trials, Other Health, Biotechnology, Pharmaceutical, Health, Science, Oncology, Burn, GBM, Vaccine, Patient, Rehovot, Disease, VBI, Public

Additionally, subject to certain approvals, VBI and Brii Bio will work together to transfer the manufacturing technologies of VBI-2601 to a site designated by Brii Bio.

Key Points: 
  • Additionally, subject to certain approvals, VBI and Brii Bio will work together to transfer the manufacturing technologies of VBI-2601 to a site designated by Brii Bio.
  • VBI received $2.5 million of consideration upon signing of definitive documents and is expected to receive up to an additional $30.5 million of consideration, subject to achievement of certain activities, with a target completion date of June 30, 2024.
  • Jeff Baxter, President and CEO of VBI, stated: “We believe that this transaction improves the financial stability of VBI and balances the potential value creation within our development and commercial portfolio with a streamlined and focused resource deployment.
  • Upon successful completion of all transactions, we anticipate that we will have reduced the long-term burn of the company, and reduced our debt overhang by about 70%.

BIRD - Israel-U.S. Binational Industrial R&D Foundation to invest $9.6 million in 10 new projects: The approved projects, with an overall budget of $24.5 million, involve innovations in the areas of Agrotech, Biotechnology, Electronics, Energy, Foodtech,

Retrieved on: 
Wednesday, January 31, 2024
Misgav, MD, BIRD Foundation, Commerce, BIRD, Planner, Associate, Partnership, Yokneam Illit, Mayo Clinic, History, TEL, Carbon, Splenic infarction, Lod, Intelligence, Sheba Medical Center, Patient, Ministry, Mondelez International, NIST, Approval, Virtual reality, Anopheles, Agriculture, Anopheles stephensi, Parity, Rehovot, ATCC, Hope, Malaria, Pharmaceutical industry

In addition to the grants from BIRD, the projects will access private-sector funding, boosting the total investment in all projects to $24.5 million.

Key Points: 
  • In addition to the grants from BIRD, the projects will access private-sector funding, boosting the total investment in all projects to $24.5 million.
  • The BIRD Foundation promotes collaborations between U.S. and Israeli companies in various technological sectors for joint product development.
  • In addition to providing conditional grants of up to $1.5 million, the Foundation assists by working with companies to identify potential strategic partners and facilitate introductions.
  • The ten projects approved by the Board of Governors are in addition to the over 1000 projects that the BIRD Foundation has approved for funding during its 46-year history.

A Record Revenue Year for Maris-Tech.

Retrieved on: 
Thursday, January 11, 2024
Artificial intelligence, Bank statement, Annual report, Rehovot

Rehovot, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK) ("Maris-Tech" or the "Company"), a B2B provider of edge computing artificial intelligence (AI) accelerated video solutions for edge platforms, today announced preliminary and partial results for 2023.

Key Points: 
  • Moreover, this financial information has been prepared solely on the basis of currently available information and is the responsibility of management.
  • This preliminary and partial financial information is not a comprehensive statement of our financial results for this period.
  • The Company expects to publish its full financial statements for the year 2023 during March 2024.
  • Our actual results and financial condition may differ materially from those indicated in the forward-looking statements.

Maris-Tech Receives $625,000 Follow-On Order for its Opal Platform from a Leading Defense Company

Retrieved on: 
Tuesday, October 31, 2023
Artificial intelligence, Rehovot, AI, Opal, Acceleration, Israel Beer

Rehovot, Israel, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of artificial intelligence (“AI”) accelerated video solutions for edge platforms, today announced a $625,000 repeat order for units of the Company’s Opal platform from a leading Israeli defense company.

Key Points: 
  • Order underscores the advanced capabilities, high performance and successful application of Maris-Tech’s innovative products in the defense market
    Rehovot, Israel, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of artificial intelligence (“AI”) accelerated video solutions for edge platforms, today announced a $625,000 repeat order for units of the Company’s Opal platform from a leading Israeli defense company.
  • The advanced Opal platform is based on Maris-Tech’s flagship Jupiter AI platform, a high-end multiple stream video platform with AI acceleration that delivers real-time intelligence gathering and analytics.
  • Maris-Tech has already delivered previously placed purchase order in the amount of $500,000 for the Opal platform.
  • Maris-Tech expects to deliver the units pursuant to this purchase order during the years 2023 and 2024.

Maris-Tech and ParaZero Technologies Expand their Collaboration into the Defense Market for Drones

Retrieved on: 
Thursday, October 12, 2023
Letter, Rehovot, AI, Safety, Artificial intelligence, OEM, Acceleration, Manufacturing, Israel Beer

Rehovot, Israel, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) ("Maris-Tech"), a B2B provider of edge artificial intelligence (“AI”) accelerated video solutions for edge platforms, and ParaZero Technologies Ltd. (Nasdaq: PRZO) (“ParaZero”), an aerospace company focused on drone safety systems, today announced an expansion of their collaboration.

Key Points: 
  • Maris-Tech and ParaZero entered into a letter of intent pursuant to which the companies will collaborate to develop a unified product, integrating safety technology and predictive maintenance.
  • Commenting on the collaboration, Israel Bar, Maris-Tech's CEO, said, "Safety in drone systems is paramount in the defense industry.
  • Our collaboration with ParaZero ensures advanced safety measures, underlining our commitment to being at the forefront of edge technologies."
  • The CEO of ParaZero, Boaz Shetzer, said, "Maris-Tech's cutting-edge video payloads and AI capabilities elevate drone safety, showcasing the future of aerospace technology for the defense industry."

Maris-Tech to Exhibit at Milipol Paris 2023: Featuring its AI-Based Intelligence Gathering and Advanced Video Payload Solutions

Retrieved on: 
Monday, October 9, 2023
Intelligence, Rehovot, AI, Annual report, Mobile phone, Israel Beer

Rehovot, Israel, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of AI accelerated video solutions for edge platforms, today announced its participation in the upcoming Milipol Paris 2023 (November 14-17,2023) at the Paris Norde Villepinte exhibition (“Milipol Paris 2023”). The Company will showcase its high-performance intelligence gathering solutions for remote and autonomous platforms – powered by artifical intelligence (“AI”) at booth 014, Hall 4E.

Key Points: 
  • The Company will showcase its high-performance intelligence gathering solutions for remote and autonomous platforms – powered by artifical intelligence (“AI”) at booth 014, Hall 4E.
  • "Maris-Tech's leading-edge products are highly regarded in the homeland security, drone, and law enforcement markets.
  • Participation in Milipol Paris 2023 is part of our continued efforts to expand the Company's commercial activities and penetrate new markets," said Israel Bar, Chief Executive Officer of Maris-Tech.
  • Milipol Paris is a leading international event for law enforcement and homeland security, highlighting technological innovations that meet current and emerging needs.